纽尔真检测 NEOG 深 沪
等待开盘 05-21 09:30:00 美东时间
8.83
+0.480
+5.75%
华盛通- 最 高8.835
- 今 开8.35
- 成交量 332.37万股
- 最 低 8.24
- 昨 收 8.35
- 总市值 19.22亿
- 52周最高 11.425
- 市盈率 静 --
- 换手率 1.53%
- 52周最低 4.5305
- 委 比 -73.26%
- 总股本 2.18亿
- 历史最高 48.85
- 量 比 1.29
- 振 幅 7.13%
- 历史最低 3.8701
- 每 手 1
- 风险率 2.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ameresco Completes Spin Off Of Its Biofuels Operations Into Newly Formed Joint Venture With HA Sustainable Infrastructure Capital; HA Sustainable To Invest $400M In New JV; Ameresco To Own 70% Stake Of JV
Ameresco, Inc. (NYSE: AMRC), a leading energy infrastructure solutions provider today announced the successful closing of its previously announced transaction with HA Sustainable Infrastructure Capital, Inc. (NYSE:HASI),
05-13 04:21
Full Transcript: Neo Performance Materials Q1 2026 Earnings Call
On Tuesday, Neo Performance Materials (TSX:NEO) discussed first-quarter financi...
05-12 23:55
HA Sustainable Infrastructure Capital declares $0.425 dividend
HA Sustainable Infrastructure Capital (HASI) declares $0.425/share quarterly dividend. Forward yield 4.0% Payable July 10; for shareholders of record July 2; ex-div July 2. See HASI Dividend Scorecard...
05-08 20:51
Ameresco Q1 2026 Earnings Call: Complete Transcript
On Monday, Ameresco (NYSE:AMRC) discussed first-quarter financial results durin...
05-05 05:39
Ameresco Forms Neogenyx Biogas Joint Venture with HASI
Ameresco ( ($AMRC) ) has provided an announcement. On May 4, 2026, Ameresco ent...
05-05 04:33
Neogen Hosts Investor Tours Highlighting Petrifilm Facility Progress
An update from Neogen ( ($NEOG) ) is now available. Neogen plans to host two in...
04-20 19:19
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines April 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen, Equinix and Revolution Medicines on Tuesday. HIGHLIGHTS * Biogen BIIB.O : Piper Sandler raises
04-14 15:45
财报速睇 | 纽尔真检测 2026财年Q1营收2.11亿美元，同比下降4.4%；归母净利润亏损0.17亿美元，同比亏损扩大56.0%
华盛资讯4月10日讯，纽尔真检测公布2026财年Q1业绩，公司Q1营收2.11亿美元，同比下降4.4%，归母净利润亏损0.17亿美元，同比亏损扩大56.0%。
04-10 04:18
Neogen shares are trading lower. The company reported Q3 financial results.
Neogen shares are trading lower. The company reported Q3 financial results.
04-09 21:15
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galmed Pharmaceuticals (NASDAQ:GLMD) stock increased by 83.2% to $1.14...
04-09 20:05
